Comparison of Different Treatment Modalities for Type 1 Diabetes, including Sensor-Augmented Insulin Regimens

Read full text Summarise with VIRAT
Authors: Akshay Shamrao Tumram
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: In recent years, diabetes care technology have advanced significantly, opening up new treatment options. The majority of type 1 diabetes patients still have subpar metabolic control, despite some promising findings. Objective: To compare different treatment modalities for patients with type 1 diabetes (T1D) based on real-time continuous glucose monitoring (RT-CGM) or self-monitoring of blood glucose (SMBG) combined with multiple daily injections (MDIs) or continuous subcutaneous insulin infusion (CSII). Methods and materials: For a year, 130 T1D patients were monitored. Of them, 27 began using RT-CGM as part of a sensor-augmented insulin regimen (SAIR); 15 individuals in this SAIR group began using sensor-augmented pump (SAP) therapy, and the remaining 12 kept using MDIs (MDIs + RT-CGM). A third group of eighteen subjects stayed on MDIs and SMBG, whereas a second group of twenty patients started CSII without RT-CGM. Reduction of HbA1c, glycemic variability (GV), and hypoglycemia incidence were the primary outcomes. Results: After a year, the SAIR group's baseline mean HbA1c dropped from 8.3% to 7.1% (P < 0.0001); improvements were similar for the SAP and MDIs + RT-CGM SAIR subgroups. Additionally, the HbA1c was lower in the CSII group (8.4% ± 0.9% vs. 7.9% ± 0.7%; P < 0.05). Both SAIRs outperformed CSII (P = 0.0032) and MDIs (P = 0.002). Additionally, GV decreased in both the CSII (P

Fields of Study & Subjects

Diabetes Management and Research Diabetes Management and Education Diabetes Treatment and Management

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
26 March 2026
Language
EN